Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for Vantictumab

1 Open Trial

    Trial Type Protocol No. &
    Open Date
    Summary

    Treatment

    VICCGI1370

    12/30/2013

    A Phase 1b Dose Escalation Study of Vantictumab (OMP-18R5) in Combination with Nab-Paclitaxel and Gemcitabine in Patients with Previously Untreated Stage IV Pancreatic Cancer


    Print this page for your doctor